We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




CT Reveals Lung Injury in Asymptomatic COVID-19 Carriers

By MedImaging International staff writers
Posted on 06 Jul 2020
Print article
Almost half of those infected by SARS-CoV-2 may never show symptoms of the disease, according to the results of a new study.

Researchers at the Scripps Research Institute (La Jolla, CA, USA) conducted a study to review and synthesize data from 16 cohorts, but did not attempt to pool them together for the purposes of statistical analysis. The datasets, which were gathered via keyword searches of PubMed, bioRxiv, and medRxiv, as well as Google searches of relevant news reports, included data on nursing home residents, cruise ship passengers, prison inmates, and various other groups.

The major difficulty was distinguishing the asymptomatic from those who are merely pre-symptomatic. While the asymptomatic are infected with SARS-CoV-2, but will never develop symptoms of COVID-19, the pre-symptomatic are similarly infected, but eventually will develop symptoms. According to the researchers, the solution is to perform longitudinal testing, i.e., repeated observations of an individual over time. But only five of the cohorts include longitudinal data, which raises the possibility that some of the proportions of asymptomatic persons are lower than reported.

The researchers concluded that approximately 40-45% of those infected with SARS-CoV-2 will remain asymptomatic, and that symptomatic persons can transmit the virus to others for an extended period, perhaps longer than 14 days, suggesting a greater potential than previously estimated to spread silently and deeply through human populations. The authors also conclude that the absence of symptoms may not imply an absence of harm, raising the possibility of SARS-CoV-2 infection impacting lung function that might not be immediately apparent. The study was published on June 3, 2020, in Annals of Internal Medicine.

“Our estimate of 40% to 45% asymptomatic means that, if you’re unlucky enough to get infected, the probability is almost a flip of a coin on whether you’re going to have symptoms. So to protect others, we think that wearing a mask makes a lot of sense,” said co-lead author behavioral scientist Daniel Oran, PhD. “Asymptomatic infections may have played a significant role in the early and ongoing spread of COVID-19, and highlight the need for expansive testing and contact tracing to mitigate the pandemic.”

“The silent spread of the virus makes it all the more challenging to control,” said professor of molecular medicine Eric Topol, MD, founder and director of the Scripps Research Translational Institute. “Our review really highlights the importance of testing. It’s clear that with such a high asymptomatic rate, we need to cast a very wide net, otherwise the virus will continue to evade us.”

Related Links:
Scripps Research Institute

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Laptop Ultrasound Scanner
PL-3018
New
X-Ray QA Meter
Piranha CT
New
Color Doppler Ultrasound System
KC20

Print article
Radcal

Channels

MRI

view channel
Image: PET/MRI can accurately classify prostate cancer patients (Photo courtesy of 123RF)

PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients

The Prostate Imaging Reporting and Data System (PI-RADS) is a five-point scale to assess potential prostate cancer in MR images. PI-RADS category 3 which offers an unclear suggestion of clinically significant... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.